Physician

Aamir Masood Gilani, M.D

According to 2025 Medicare claims, Aamir Gilani, M.D (NPI: 1003072612) practices pulmonary disease in the Kiryas Joel-Poughkeepsie-Newburgh, NY market, with the plurality of this provider's patient population coming from Orange, NY. This provider's primary affiliated billing organization is GARNET HEALTH DOCTORS PC (NPI: 1093138851; TIN: 37-1743537) and primary practice location at 10940-2650. Gilani is affiliated with the Bassett Accountable Care Partners, LLC (ACO ID: A2612), participating under the MSSP model.

Gilani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 443 traditional Medicare patients, billed 1,269 HCPCS/CPT codes, and received $150,765 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 1,675 prescription claims across 168 beneficiaries totaling $741,660 in drug costs, led by Dupixent Pen (Dupilumab). DME data shows 494 claims. Open Payments data shows 2 records totaling $43. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $7,749 to $150,765. Similarly, Part D prescription costs have moved sharply higher in recent years, from $18,528 to $741,660. For DME billing, reported payments rose steadily, from $4,367 to $68,026.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	40	91	$7,749
2016	243	708	$65,304
2017	429	1,524	$154,814
2018	436	1,425	$157,034
2019	514	1,509	$161,081
2020	425	1,293	$144,703
2021	469	1,329	$163,217
2022	422	1,265	$155,903
2023	394	1,197	$136,422
2024	443	1,269	$150,765

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	20	82	$18,528
2016	39	192	$26,470
2017	56	363	$67,501
2018	78	523	$149,331
2019	87	621	$188,024
2020	77	615	$236,386
2021	131	723	$359,402
2022	137	1,437	$781,739
2023	160	1,655	$848,537
2024	168	1,675	$741,660

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	179	$29,361
2017	N/R	240	$52,016
2018	49	399	$94,556
2019	68	566	$123,499
2020	57	612	$125,933
2021	93	646	$131,850
2022	82	631	$151,004
2023	37	529	$90,688
2024	49	494	$77,420

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	164	452	$177
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	71	72	$145
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	100	191	$101
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	148	214	$99
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	42	54	$66

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Pen	Dupilumab	27	1,036	$135,142
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	181	5,775	$121,479
Nucala	Mepolizumab	23	794	$104,346
Prolastin C	Alpha-1-Proteinase Inhibitor	11	301	$79,719
Xolair	Omalizumab	27	756	$58,367

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	46	$45,990
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	23	172	$13,334
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	12	$9,195
E1392	Portable oxygen concentrator, rental	Y	14	103	$3,911
K0738	Portable gaseous oxygen system, rental; home compressor used to fill portable oxygen cylinders; includes portable containers, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	35	$1,340

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$43	Harmony Biosciences Llc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aamir Masood Gilani, M.D?

Tedicare shows public-source Medicare data for Aamir Masood Gilani, M.D (NPI 1003072612), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aamir Masood Gilani, M.D have ACO affiliation data?

Aamir Masood Gilani, M.D is shown with ACO affiliation data for Bassett Accountable Care Partners, LLC (MSSP, ACO ID A2612).

What billing organization is linked to Aamir Masood Gilani, M.D?

Aamir Masood Gilani, M.D is linked to GARNET HEALTH DOCTORS PC (billing NPI 1093138851) in the available physician profile data.

Does Aamir Masood Gilani, M.D have Open Payments data?

Aamir Masood Gilani, M.D has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.